Qi Zhou

How risky are stem cell trials for Parkinson’s beginning in China?

Brain-PET-scan, stem cells

New human clinical trials using derivatives of pluripotent stem cells in China for Parkinson’s Disease (PD) have raised expectations and some eyebrows. PD is a neurodegenerative condition, sometimes diagnosed or followed by PET scans such as the one at left, characterized by loss of dopaminergic neurons leading to severe and sometimes life-threatening symptoms. Pluripotent stem …

How risky are stem cell trials for Parkinson’s beginning in China? Read More »

NAS Meeting on Human Germline Modification Taking Shape

NAS-CRISPR3

The US National Academy of Sciences (NAS) will hold a meeting on heritable human germline modification on December 1-3, 2015 in Washington, D.C. Invitations to the NAS meeting to individuals starting going out last week. The upcoming NAS meeting seeks to address these issues and discuss the possibility of a moratorium on clinical use of …

NAS Meeting on Human Germline Modification Taking Shape Read More »